A highly sensitive, low input, and automated assay for molecular residual disease detection (MRD) using whole-genome sequencing (WGS).
Li Liu(Qatar Airways (Qatar)), Traci Pawlowski(Illumina (United States)), Manh Quang Vu(Illumina (United States)), Jeff H. Tsai(Illumina (United States)), Sven Bilke(Illumina (United States)), Peter Taylor(Cardiff University), Artem Movsesyan(Illumina (United States)), Khai Luong(Pacific Biosciences (United States)), Jacquelyn Truong(Illumina (United States)), Yunjiao Zhu(Illumina (United States)), Heather Talia(Illumina (United States)), Yuan Ding(Southwest Jiaotong University), Fan Song(Illumina (United States)), Weixin Wu(Illumina (United States)), Jacob Gibson(Illumina (United States)), Kyria Roessler(Illumina (United States)), Michael Davila(Illumina (United States)), James Han(Illumina (United States))
Cited by 0
Related Papers
Epithelial–mesenchymal plasticity in carcinoma metastasis
|Genes & Development|2013|1.1k
Changes in circulating microRNA levels associated with prostate cancer
|British Journal of Cancer|2012|717